Save Entresto for Persistent Heart Failure Symptoms

September 2015

You'll hear lots of buzz about Entresto (en-TRESS-toh), a new drug for systolic heart failure.

It's the first "angiotensin receptor neprilysin inhibitor" (ARNI)...and combines valsartan with sacubitril (sah-KYOO-bih-tril).

Sacubitril works by inhibiting the enzyme neprilysin. This increases sodium loss and vasodilation...and enhances ARB efficacy.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote